Market Tracker

09/22 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

10.99
Delayed Data
As of Sep 22
 +0.18 / +1.67%
Today’s Change
5.90
Today|||52-Week Range
25.17
+6.91%
Year-to-Date

Today’s Trading

Previous close10.81
Today’s open10.72
Day’s range10.38 - 11.74
Volume4,795,993
Average volume (3 months)1,807,637
Market cap$323.3M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+5.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.12-2.65%
SBBPStrongbridge Biophar...+0.15+2.03%
NEOSNeos Therapeutics In...-0.10-1.12%
DRRXDURECT Corp+0.04+2.37%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts